NCT01952795

Brief Summary

The purpose of this study is to determine the impact of diet and physical exercise program on pregnancy rate and live birth in obese women who undergo an IVF cycle.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 30, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

August 22, 2017

Status Verified

August 1, 2017

Enrollment Period

2.1 years

First QC Date

September 23, 2013

Last Update Submit

August 21, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rate

    Pregnancy rate by cycle

    14 days after embryo transfer

Secondary Outcomes (7)

  • Hyperstimulation rate

    At luteal phase and first weeks of pregnancy

  • Fertility rate

    24 hours post pick up

  • Mature oocytes

    Pick up day

  • Cancellation rate

    Durinf the stimulation in follicular phase

  • Good quality embryos

    Day 3 to 5 post pick up

  • +2 more secondary outcomes

Other Outcomes (1)

  • Leptin, adiponectin, resistin, interleukin VI, TNF-α, visfatin, IGF1 and PAI I

    During the stimulation phase

Study Arms (2)

Diet and exercise

ACTIVE COMPARATOR

Total caloric intake aimed at maintaining a diet with\> 50% of the caloric content in the form of carbohydrates, less than 10% in the form of saturated fats and 20% from monounsaturated / polyunsaturated (if applicable, up to 25% fat monounsaturated), less than 300 mg / day of dietary cholesterol and about 1.0 g of protein / kg ideal body weight / day. 3 sessions per week on a bicycle ergometer or on a treadmill (according to body fat distribution and other parameters) modifications carried out weekly, with a gradual increase as to exercise until maximal oxygen consumption 60 - 70% would always preceded by heating 5 minutes.

Behavioral: Diet and exercise

No intervention

NO INTERVENTION

Usual diet and exercise

Interventions

Total caloric intake aimed at maintaining a diet with\> 50% of the caloric content in the form of carbohydrates, less than 10% in the form of saturated fats and 20% from monounsaturated / polyunsaturated (if applicable, up to 25% fat monounsaturated), less than 300 mg / day of dietary cholesterol and about 1.0 g of protein / kg ideal body weight / day.

Diet and exercise

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women who want pregnancy.
  • Basal FSH levels ≤ 10 IU / l.
  • Infertility to justify treatment with IVF/ICSI.
  • Being included in a long protocol with GnRH agonist.
  • Presence of both ovaries and uterus able to support embryo implantation and pregnancy.
  • Body mass index (BMI) ≥ 30 kg/m2 and ≤ 35 kg/m2.
  • Absence of pregnancy before starting ovarian stimulation.
  • Having given their written consent.

You may not qualify if:

  • Female age ≤ 18 years and ≥ 35 years.
  • Severe male factor not permit an IVF-ICSI with ejaculated sample.
  • Patients with low ovarian reserve (basal FSH levels ≥ 10 IU / l or lower antral follicle count to 6 follicles in both ovaries).
  • HIV seropositivity, HBV or HCV.
  • Clinically important disease.
  • Having frozen embryos from previous cycles of assisted reproduction.
  • Unexplained vaginal bleeding.
  • Poor response in previous IVF cycles with standard stimulation protocols
  • Any contraindication to become pregnant.
  • Known allergy to preparations of gonadotropins or its excipients.
  • High consumption of alcohol, drugs or psychotropic drugs.
  • Concurrent participation in another study.
  • Patients who have done previous cycles of IVF / ICSI without success

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, 08025, Spain

Location

MeSH Terms

Conditions

Obesity

Interventions

DietExercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Juan José Espinós-Gómez, MD

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2013

First Posted

September 30, 2013

Study Start

November 1, 2013

Primary Completion

December 1, 2015

Study Completion

April 1, 2016

Last Updated

August 22, 2017

Record last verified: 2017-08

Locations